Wolverine blend dosage chart by schedule

The first two rows are the two peptides on their own, with the sources and caveats from their own dosage pages. The third row is the one study that tested the pair, in rats. Background on the blend is on the Wolverine blend page.

That study dosed by body weight. Rat doses don't convert to people by weight, so it isn't a human amount. What a one-vial blend gives each peptide is worked through under "When and how often" below.

The blend is sold as a freeze-dried powder with BPC-157 and TB-500 in one vial. You mix it with bacteriostatic water, which is sterile water with a preservative so one vial can be drawn from more than once. The math below assumes equal parts of each peptide, so a 10 mg vial is 5 mg of each. Vendors choose the ratio and the label can show the total or the amount of each, so check which before you use these numbers.

The tables show units on a U-100 syringe, which holds 100 units in 1 mL, for 1, 2 and 3 mL of water. Each draw is the total of both peptides, so a 500 mcg draw is 250 mcg of each, a 1,000 mcg draw is 500 mcg of each, a 4,000 mcg draw is 2 mg of each, and a 5,000 mcg draw is 2.5 mg of each.

Units are math from the chart amounts, with strength rounded to the nearest whole number. "Over one syringe" means the draw is more than the 100 units a 1 mL syringe holds. The ratio stays the same whatever the water, and only the concentration changes.

A 20 mg vial with 1 mL of water makes a 500 mcg draw only 2.5 units, which is hard to read, so 2 or 3 mL suits the bigger vial. For any other vial, water or amount, the reconstitution calculator does the same math.

The schedules don't match. On their own, BPC-157 is given once or twice a day and TB-500 twice a week for 4 to 6 weeks, then weekly or every other week. One vial can follow only one of those.

Daily keeps BPC-157 on its pattern. At 250 to 500 mcg of each a day, TB-500 gets 1.75 to 3.5 mg a week, which is less than the 4 to 5 mg it gets on its own, and it gets it in seven small doses instead of two. That is our math, assuming equal parts.

Twice a week keeps TB-500 on its pattern. At 2 to 2.5 mg of each, BPC-157 gets 4 to 5 mg a week, inside the 1.75 to 7 mg a week its daily pattern adds up to, but in two doses 4 to 10 times the size of its usual single dose. That is our math too.

A different ratio changes both. If the blend isn't equal parts, each number above moves with it, which is another reason to check what the vial holds.

Injection site and time of day. Vendor education pages describe an abdomen injection under the skin, or one near the area of concern, with the spot rotated. No study or label sets a time of day.

For planning, 8 weeks of a daily blend at 500 to 1,000 mcg total is 28 to 56 mg in all. Compare vendors on price per milligram against the amount of each peptide you actually need, not on the price of one vial.

A mixed vial goes on a 28-day clock in the fridge the day water goes in, however much of it gets used. A 10 mg vial lasts 20 days at 250 mcg of each a day and 10 days at 500 mcg of each. A 20 mg vial at 250 mcg of each holds 40 days of blend, but the mixed vial expires at day 28, so about 6 mg goes unused. At 500 mcg of each it lasts 20 days.

On the twice-weekly pattern, a 10 mg vial gives 2 full doses of 4 mg total (2 mg of each), about 7 days, with 2 mg left over, and at 5 mg total (2.5 mg of each) it gives 2 full doses with nothing left. A 20 mg vial gives 5 doses of 4 mg total over 17.5 days, or 4 doses of 5 mg total over 14 days. Eight weeks of the daily blend takes about three 10 mg vials at 250 mcg of each, and six at 500 mcg of each. At 500 mcg of each a day, a 20 mg vial is used up in 20 days with nothing wasted.

Two vials let each peptide keep its own schedule and its own ratio, at the cost of more injections and two prices to compare. The blend is one injection and one vial, with one schedule and a ratio the vendor picked. Vendor education pages usually describe keeping them on the separate schedules from the single-peptide charts. See BPC-157 dosage and TB-500 dosage, and the BPC-157 vs. TB-500 comparison to weigh them. The blend is an injection only, and BPC-157's oral amounts are sold as separate capsules.

These are reported experiences from people who run BPC-157 and TB-500, not findings from a study of the blend.

Redness or irritation at the injection site that lasts. Mild, brief redness is the report you see most. People rotate the spot, and some stop if it carries on past a short flush.

Cloudy or discolored liquid. People report throwing out a mixed vial that was clear and has turned cloudy or shows particles, rather than using it. The 28-day clock applies to the whole vial.

No completed large human safety study exists for either peptide, and none exists for the pair in people. The open questions are laid out on the BPC-157 page and the TB-500 page.